Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,512.38 -3.89 -0.03%
TOPIX 1,171.40 -1.97 -0.17%
HANG SENG 22,760.24 64.23 0.28%

MEDISTEM INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout



  MEDISTEM INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces
  Investigation of Buyout

Business Wire

WILMINGTON, Del. -- January 5, 2014

Rigrodsky & Long, P.A.:

  * Do you own shares of Medistem Inc. (OTC QB: MEDS)?
  * Did you purchase any of your shares prior to December 20, 2013?
  * Do you think the proposed buyout price is too low?
  * Do you want to discuss your rights?

Rigrodsky & Long, P.A. announces that it is investigating potential legal
claims against the board of directors of Medistem Inc. (“Medistem” or the
“Company”) (OTC QB: MEDS) regarding possible breaches of fiduciary duties and
other violations of law related to the Company’s entry into an agreement to be
acquired by Intrexon Corporation (“Intrexon”) (NYSE: XON), in a transaction
valued at approximately $26 million.

Click here to learn more:
http://www.rigrodskylong.com/investigations/medistem-inc-meds.

Under the terms of the agreement, public shareholders of Medistem will receive
$0.27 in cash and $1.08 worth of Intrexon common stock for each share of
Medistem they own.

The investigation concerns whether Medistem’s board of directors failed to
adequately shop the Company and obtain the best possible value for Medistem’s
shareholders before entering into an agreement with Intrexon.

If you own the common stock of Medistem and purchased your shares before
December 20, 2013, if you have information or would like to learn more about
these claims, or if you wish to discuss these matters or have any questions
concerning this announcement or your rights or interests with respect to these
matters, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky &
Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, New York 11530,
by telephone at (888) 969-4242; by e-mail to info@rl-legal.com, or at:
http://www.rigrodskylong.com/investigations/medistem-inc-meds.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City,
New York, regularly prosecutes securities class, derivative and direct
actions, shareholder rights litigation and corporate governance litigation, on
behalf of shareholders in states and federal courts throughout the United
States.

Attorney advertising. Prior results do not guarantee a similar outcome.

Contact:

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
888-969-4242
516-683-3516
Fax: 302-654-7530
info@rl-legal.com
http://www.rigrodskylong.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement